Video Experimental Relacionado

Updated: Feb 17, 2026

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines

Published on: March 5, 2019

El momento de los glucocorticoides antenatales determina la sensibilidad del receptor en lactantes prematuros

Ingmar Fortmann^1,2, Jan Hendric Britsemmer³, Marianne Lehmann⁴

¹Department of pediatrics, University Hospital Schleswig-Holstein (UKSH), Campus Lübeck, Lübeck 23562, Germany.

The Journal of clinical endocrinology and metabolism

|February 16, 2026

Abstracto

Context:

The global preterm birth rate is about 11%, most of premature (PI) infants receive antenatal glucocorticoids (aGC) to accelerate fetal lung maturation, however, this treatment increases the vulnerability for immune disorders later in life.

Objective:

We hypothesized that aGC given at the "wrong" time of day, determines the vulnerability. We compared the effect of aGCs in PI exposed in the morning (in-phase, IP with the maternal circadian rhythms) and in the evening (out-of-phase, OP) to controls (C).

Design And Setting:

We collected data and blood samples from infants enrolled in a population-based cohort study. Groups are balances in gestational age, birth weight and sex. Infants were divided depending on the time of maternal cortisol peak. Exclusion criteria was established by the cohort, additionally infants born before gestational week 24 and exposed to postnatal GCs were excluded.

Patients:

The study was run in sub-cohorts, GC receptor (GR) sensitivity was assessed on 6 IP and 6OP. RNA sequencing, RNA expression and DNA methylation was assessed in peripheral blood cells from 13 C, 17 IP and 17 OP. All samples were obtained on average 10 days after birth.

Interventions:

No interventions were performed.

Results:

OP infants exhibited reduced GR sensitivity and suppressed expression of genes involved in antibody production, leucocyte migration, antigen presentation.

Conclusions:

aGCs exposure aligned with the maternal GC rhythms, would be advisable to improve PI's capacity to fight against pathogens in the first weeks of life.

Palabras clave:

receptor de glucocorticoides células mononucleares de sangre periférica lactantes prematuros glucocorticoides prenatales

Más Videos Relacionados

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

P50 Sensory Gating in Infants

P50 Sensory Gating in Infants

Published on: December 26, 2013

Videos de Conceptos Relacionados

Factors Affecting Drug Response: Overview

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...